Relief Therapeutics Holding AG (RLF):企業の財務・戦略的SWOT分析

◆英語タイトル:Relief Therapeutics Holding AG (RLF) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH2801531FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Relief Therapeutics Holding AG (Relief Therapeutics) is a drug development company that offers clinical development of peptides and proteins of natural or engineered origin. Its pipeline drug candidates include aviptadil for the treatment of sarcoidosis and low dose interleukin-6 to treat peripheral diabetic neuropathy. It develops treatment for diabetic complications and respiratory diseases. Relief Therapeutics’s drug candidate, Aviptadil development in sarcoidosis focuses the drug on an orphan disease market. The company has operations in Geneva and Zurich, Switzerland. Relief Therapeutics is headquartered in Geneve, Switzerland

Relief Therapeutics Holding AG Key Recent Developments

Apr 07,2021: Relief engages Jan-Jaap Scherpbier of Sonsbeek Pharma Consultancy B.V. as Manufacturing and Supply Chain Consultant
Mar 22,2021: Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease
Jan 25,2021: Relief Therapeutics and Acer Therapeutics Sign Option Agreement for Exclusivity to Negotiate a Collaboration and License Agreement for the Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Ur
Dec 21,2020: Relief appoints Chris L.J.J. Stijnen as Chief Commercial Officer
Dec 18,2020: Relief announces results of extraordinary general meeting of RELIEF THERAPEUTICS approved with large majority

This comprehensive SWOT profile of Relief Therapeutics Holding AG provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Relief Therapeutics Holding AG including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Relief Therapeutics Holding AG – Key Information
Relief Therapeutics Holding AG – Overview
Relief Therapeutics Holding AG – Key Employees
Relief Therapeutics Holding AG – Key Employee Biographies
Relief Therapeutics Holding AG – Key Operational Heads
Relief Therapeutics Holding AG – Major Products and Services
Relief Therapeutics Holding AG – History
Relief Therapeutics Holding AG – Company Statement
Relief Therapeutics Holding AG – Locations And Subsidiaries
Relief Therapeutics Holding AG
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Relief Therapeutics Holding AG – Business Description
Relief Therapeutics Holding AG – Corporate Strategy
Relief Therapeutics Holding AG – SWOT Analysis
SWOT Analysis – Overview
Relief Therapeutics Holding AG – Strengths
Relief Therapeutics Holding AG – Weaknesses
Relief Therapeutics Holding AG – Opportunities
Relief Therapeutics Holding AG – Threats
Relief Therapeutics Holding AG – Key Competitors

Section 3 – Company Financial Performance Charts

Relief Therapeutics Holding AG – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Relief Therapeutics Holding AG, Key Information
Relief Therapeutics Holding AG, Key Ratios
Relief Therapeutics Holding AG, Share Data
Relief Therapeutics Holding AG, Major Products and Services
Relief Therapeutics Holding AG, History
Relief Therapeutics Holding AG, Key Employees
Relief Therapeutics Holding AG, Key Employee Biographies
Relief Therapeutics Holding AG, Key Operational Heads
Relief Therapeutics Holding AG, Other Locations
Relief Therapeutics Holding AG, Subsidiaries
Relief Therapeutics Holding AG, Key Competitors
Relief Therapeutics Holding AG, SWOT Analysis
Relief Therapeutics Holding AG, Ratios based on current share price
Relief Therapeutics Holding AG, Annual Ratios
Relief Therapeutics Holding AG, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Relief Therapeutics Holding AG (RLF):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Baker Hughes Incorporated (BHGE)-石油・ガス分野:企業M&A・提携分析
    Summary Baker Hughes Incorporated (Baker Hughes), a subsidiary of General Electric Co is a provider of oil and gas equipment and services. The company is a supplier of oilfield services, products, technology and systems to oil and gas industry. It also offers industrial and other products and servic …
  • Sunovion Pharmaceuticals Inc:企業の戦略的SWOT分析
    Sunovion Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • NLC India Ltd:発電所・企業SWOT分析
    NLC India Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exec …
  • Hindustan Aeronautics Ltd:企業の戦略・SWOT・財務情報
    Hindustan Aeronautics Ltd - Strategy, SWOT and Corporate Finance Report Summary Hindustan Aeronautics Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Coca-Cola Amatil Ltd (CCL):企業の財務・戦略的SWOT分析
    Coca-Cola Amatil Ltd (CCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Shields Bag And Printing Company:企業の戦略・SWOT・財務分析
    Shields Bag And Printing Company - Strategy, SWOT and Corporate Finance Report Summary Shields Bag And Printing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • SYNNEX Corp (SNX):企業の財務・戦略的SWOT分析
    SYNNEX Corp (SNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Compagnie Financiere Richemont SA:戦略・SWOT・企業財務分析
    Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report Summary Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Gerdau S.A.:企業の戦略・SWOT・財務情報
    Gerdau S.A. - Strategy, SWOT and Corporate Finance Report Summary Gerdau S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Novant Health Inc:企業の戦略的SWOT分析
    Novant Health Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • RELX Group plc:企業の戦略・SWOT・財務情報
    RELX Group plc - Strategy, SWOT and Corporate Finance Report Summary RELX Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Cornerstone OnDemand, Inc.:企業のM&A・事業提携・投資動向
    Cornerstone OnDemand, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cornerstone OnDemand, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Furukawa Electric Co Ltd (FUWAY):企業の財務・戦略的SWOT分析
    Furukawa Electric Co Ltd (FUWAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Exco Resources Inc (XCOOQ):石油・ガス:M&Aディール及び事業提携情報
    Summary Exco Resources Inc (Exco Resources) is an oil and gas company that offers crude oil and natural gas. The company offers acquisition, exploration, development, exploitation, operations, management, and production of onshore natural gas and oil assets. It provides services such as portfolio re …
  • HealthTronics Inc:企業の戦略的SWOT分析
    HealthTronics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Reata Pharmaceuticals Inc (RETA):製薬・医療:M&Aディール及び事業提携情報
    Summary Reata Pharmaceuticals Inc (Reata) is a clinical-stage biopharmaceutical company that develops innovative medicines for the treatment of serious and life-threatening diseases. The company’s clinical candidates include bardoxolone methyl and omaveloxolone, which target Nrf2, a transcription fa …
  • QPS Austria GmbH-製薬・医療分野:企業M&A・提携分析
    Summary QPS Austria GmbH (QPS), a subsidiary of QPS Holdings LLC, is a contract research organization that performs preclinical and clinical research. The company offers in vivo services which involves generating, characterizing and maintaining transgenic disease models and use them for drug testing …
  • Westinghouse Air Brake Technologies Corporation:企業の戦略・SWOT・財務情報
    Westinghouse Air Brake Technologies Corporation - Strategy, SWOT and Corporate Finance Report Summary Westinghouse Air Brake Technologies Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • BOOM Logistics Ltd (BOL):企業の財務・戦略的SWOT分析
    BOOM Logistics Ltd (BOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • ImevaX GmbH-製薬・医療分野:企業M&A・提携分析
    Summary ImevaX GmbH (ImevaX) is a biopharmaceutical company that develops specific vaccines against chronic infections. The company identifies and uses immune modulatory bacterial factors to develop specific vaccines. It develops specific vaccines against pathogens that cause chronic infectious dise …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆